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Abstract 1 
Objectives: The study surveyed practising cochlear implant audiologists with the aim of: (1) 2 
characterising UK clinical practice around the management and fitting of a contralateral 3 
hearing aid in adult unilateral cochlear implant users (‘bimodal aiding’); (2) identifying 4 
factors that may limit the provision of bimodal aiding; and (3) ascertaining the views of 5 
audiologists on bimodal aiding.  6 
Methods: An online survey was distributed to audiologists working at the 20 centres 7 
providing implantation services to adults in the UK. 8 
Results: Responses were received from 19 of the 20 centres. The majority of centres 9 
reported evaluating hearing aids as part of the candidacy assessment for cochlear 10 
implantation. However, a majority also indicated that they do not take responsibility for the 11 
contralateral hearing aid following implantation, despite identifying few practical limiting 12 
factors. Bimodal aiding was viewed as more beneficial than wearing the implant alone, with 13 
most respondents actively encouraging bimodal listening where possible. Respondents 14 
reported that fitting bimodal devices to take account of each other’s settings was potentially 15 
more beneficial than independently-fit devices, but such sympathetic fitting was not routine 16 
practice in any centre. 17 
Discussion: The results highlight some potential inconsistencies in the provision of bimodal 18 
aiding across the UK as reported by practising audiologists. The views of audiologists about 19 
what is best practice appear to be at odds with the nature and structure of the services 20 
currently offered.  21 
Conclusion: Stronger evidence that bimodal aiding can be beneficial for UK patients would 22 
be required in order for service providers to justify the routine provision of bimodal aiding 23 
and to inform guidelines to shape routine clinical practice. 24 
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Introduction 49 
Cochlear implantation was originally devised as a method for restoring a sensation of sound 50 
in bilateral sensorineural hearing impairment where the degree of loss was total or 51 
profound (Ramsden, 2013). A consensus statement from the US National Institutes of 52 
Health (NIH) in the late 1980s demonstrated that cochlear implantation was largely 53 
restricted to individuals who could derive no real benefit from acoustic hearing aids and no 54 
open set speech discrimination (Kohut et al., 1988). A subsequent NIH consensus statement 55 
acknowledged that listening performance of some adults with a severe-to-profound hearing 56 
impairment was poorer than that of adults with a more profound impairment but who used 57 
a cochlear implant (Gates et al., 1995). As a result, a relaxation of candidacy criteria was 58 
recommended to include individuals with up to 30% open-set speech discrimination in their 59 
best aided condition in the US. 60 
 61 
At approximately the same time in the UK, a national study group was evaluating outcomes 62 
following cochlear implantation in patients who either had no open-set speech 63 
discrimination before implantation (“traditional candidates”) or who had some measurable 64 
discrimination (“marginal hearing aid users”) (UKCISG, 2004a). The study group concluded 65 
that those patients who had some usable residual hearing pre-operatively (i.e. non-66 
traditional candidates, or “marginal hearing aid users”) can have favourable odds of 67 
benefitting from cochlear implantation, particularly those with shorter durations of 68 
deafness, and therefore should be considered as candidates for the treatment.  69 
 70 
In 2009, the National Institute for Health and Care Excellence (NICE) in the UK reviewed the 71 
evidence for the effectiveness and cost-effectiveness of cochlear implantation in adults 72 
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(NICE, 2009). As a result of their appraisal of the evidence, NICE recommended unilateral 73 
cochlear implantation for adults with a bilateral severe-to-profound sensorineural hearing 74 
impairment who derive “insufficient” benefit from acoustic hearing aids. Insufficient benefit 75 
was defined as an inability to report at least 50% of words on an open-set test of speech 76 
discrimination in quiet while in their best-aided condition. The effective result of these 77 
recommendations was an expansion of the eligibility criteria which led to an associated 78 
increase in the number of hearing impaired individuals that would be suitable for the 79 
treatment. When the NICE guidance was published, approximately 900 adults were 80 
implanted each year across 14 hospitals (NHS, 2012), a level of activity which had increased 81 
to 1161 by 2014 across 19 implanting centres (BCIG, 2015). As candidacy criteria in the UK 82 
now permit candidates to have measurable open-set speech perception but still restrict 83 
implantation to one ear (thus retaining the audiological status of the non-implanted ear), 84 
many implant recipients in the UK now have measurable residual hearing and potentially 85 
aidable thresholds in their non-implanted ear. 86 
 87 
Bimodal aiding is the practice of providing and fitting an acoustic hearing aid (HA) in one ear 88 
and a cochlear implant (CI) in the other ear. Improvements in listening abilities from using 89 
both devices over using the CI alone (bimodal benefits) have been widely documented, and 90 
are thought to reflect the integration of low frequency acoustic cues from the HA with 91 
higher frequency cues from the CI (Gantz and Turner, 2003). Despite the fact that unilateral 92 
cochlear implantation is the current treatment for adults with severe-to-profound hearing 93 
losses in the UK (NICE, 2009), the restoration of binaural hearing whether through bilateral 94 
implantation or bimodal listening has been recommended for this patient group (point 1.1; 95 
NHS, 2013). 96 
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 97 
A systematic review of the evidence for bimodal aiding in adults found that wearing a 98 
contralateral HA in addition to a CI can provide benefits to speech perception, particularly in 99 
the presence of background noise (Olson and Shinn, 2008). These bimodal benefits to 100 
speech perception have been observed even when the information accessible to the non-101 
implanted ear cannot support any useful speech perception on its own (Zhang et al., 2010), 102 
suggesting that there may be supra-additive benefits from combining acoustic with electric 103 
hearing. Other studies have suggested that the benefits are not supra-additive but simply 104 
reflect the fact that CI users may be able to integrate electric and acoustic information 105 
optimally (Micheyl and Oxenham, 2012). Bimodal aiding has also been shown to improve 106 
music perception (Kong et al., 2004) and the naturalness of speech (Sucher and McDermott, 107 
2009), and may improve sound localisation in some listeners (Dunn et al., 2005). The 108 
evidence has led some to recommend that bimodal aiding should be offered routinely when 109 
listeners are able to make some use of both devices (Ching et al., 2004). 110 
 111 
The size of bimodal benefit that patients receive has been found to relate to the level of 112 
acoustic hearing in their non-implanted ear (Zhang et al., 2013). Accordingly, many studies 113 
that have demonstrated bimodal benefits have done so in patients who have access to a 114 
level of hearing in their non-implanted ear that is readily aidable using an acoustic hearing 115 
aid (Morera et al., 2005, Yoon et al., 2012) and therefore greater than that typically 116 
available to patients in the UK who meet NICE criteria. Despite this, there is evidence that 117 
UK patients report benefits from wearing a HA in addition to their CI and may derive 118 
benefits to speech perception from doing so (Visram, 2012). Other bimodal benefits that 119 
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have been observed in UK patients include some ability to distinguish emotions in spoken 120 
sentences and an improved ability to determine the location of sounds (Goman, 2014). 121 
 122 
The importance of an appropriately fit HA for use in combination with a CI has been well 123 
documented (Ching et al., 2004, Dunn et al., 2005, Gifford et al., 2007, Kong et al., 2005, 124 
Mok et al., 2006, Gifford et al., 2010). To date, professional bodies in the UK including the 125 
British Cochlear Implant Group (BCIG), the British Society of Audiology (BSA) and the British 126 
Academy of Audiology (BAA) have yet to issue guidance on the provision of HAs that are to 127 
be used simultaneously with a CI in the other ear, and how the two devices should be fit to 128 
work sympathetically together. It is therefore unclear whether clinicians providing CI 129 
services in the UK undertake HA evaluations or consider the potential benefits of bimodal 130 
aiding when assessing candidacy, when considering which ear should be implanted to 131 
maximise benefit, when fitting the CI, or when reviewing progress following implantation. 132 
The aim of this study was therefore to survey audiologists across UK adult CI centres about 133 
their current practice around bimodal aiding. The objectives of the survey were: 134 
1. To describe current clinical practice in the UK around bimodal aiding in adults 135 
2. To identify factors potentially limiting clinical practice around bimodal aiding 136 
3. To characterise audiologists’ views of bimodal aiding 137 
 138 
Methods 139 
Design 140 
The survey (Supplementary Material 1) was designed to characterise clinical practice around 141 
bimodal aiding by following the temporal progression of a patient through the care pathway 142 
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from candidacy assessment through to the choice of ear for implantation, initial activation 143 
of the CI, and post-implantation follow up. Questions types were varied and included: (i) 144 
scaling to estimate patient numbers or importance ratings; (ii) agreement/disagreement 145 
using a five-point Likert scale; (iii) frequency of occurrence using both yes/no and 146 
always/sometimes/rarely/never response sets (reflecting degree of certainty); and (iv) 147 
open-ended questions where free-text responses were permitted.  148 
 149 
Most questions were designed to elicit a response, and respondents were not permitted to 150 
proceed to the next question until a response to the current question had been provided. 151 
Responses to open-ended questions were always optional. Conditional question pathways 152 
were included so that each respondent was presented with a set of questions that were 153 
deemed appropriate based on their previous responses. For example, questions about the 154 
manner in which HAs are fit at the candidacy assessment stage were not presented to 155 
respondents who had previously indicated that they never fit HAs at that stage of the care 156 
pathway. 157 
 158 
Distribution 159 
The survey was distributed online using the Survey Monkey software 160 
(https://www.surveymonkey.com/). The survey was targeted at audiologists working at CI 161 
centres within the UK. An invitation to complete the online survey was distributed to every 162 
BCIG member indicating it was for the attention of audiologists working with adult patients. 163 
The introductory text of the survey indicated that only those who work with adult patients 164 
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should complete the survey. No option was given to complete the survey on paper. Sixty-six 165 
audiologists were registered with audiology-related job titles on the BCIG mailing list at the 166 
time of mailing (January 2015), which included representatives from the 20 UK CI centres 167 
that work with adult patients. Programme coordinators were also invited to forward the 168 
survey to any audiologist who may not be a member of the BCIG. A follow up letter and 169 
poster for placement in communal areas such as staff rooms was sent to the coordinator of 170 
each CI centre one month after the initial invitation was sent. After a further three months, 171 
coordinators of CI centres who had not yet contributed were sent a reminder email or were 172 
contacted by telephone.  173 
 174 
Procedure 175 
Respondents were informed that the purpose of the survey was to investigate current 176 
practice around evaluating, fitting and reviewing patients who use (or could use) bimodal 177 
devices. Respondents were asked to name the CI centre in which they worked. This 178 
information was collected to determine the geographical distribution of responses and to 179 
assess whether the results were likely to be representative of current practice across the 180 
UK. Respondents were informed that their responses would be strictly anonymous. 181 
Accordingly, in reporting the results individual responses have not been associated with any 182 
particular CI centre. While acknowledging that every patient is an individual, respondents 183 
were asked to think about the things they would typically do and to focus on their practice 184 
within the last 5 years. 185 
 186 
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Analysis 187 
The survey was divided into three sections based on relevance to the study objectives. 188 
Sections were not equal in length, given the greater complexity of certain aspects of clinical 189 
practice than others. No question contributed to more than one section. The number of 190 
responses varied across questions due to the use of conditional question pathways and the 191 
fact that respondents were not required to answer to all questions. Where possible, 192 
individual responses were converted to a binary outcome by grouping them into one of two 193 
categories (e.g. agree/disagree, yes/no, etc.). Responses were then summarised as the 194 
proportion of centres from which positive responses were received and as the proportion of 195 
individuals who responded positively. Ninety-five percent confidence intervals were 196 
calculated for each of these proportions (Newcombe, 1998). 197 
 198 
The terms ‘majority’ and ‘minority’ were applied only to proportions that were found to be 199 
significantly greater than or less than 50% of respondents, respectively. For example, if data 200 
were available from 19 centres on a particular question, a proportion of 26% or less (5 201 
centres or fewer) was interpreted as a ‘minority’ (upper 95% confidence interval of 202 
proportion = 48.8%) and a proportion of 74% or more (at least 14 centres) was interpreted 203 
as a ‘majority’ (lower 95% confidence interval of proportion = 51.2%). Where questions 204 
contained an estimation of the frequency of a clinical activity or procedure 205 
(always/often/sometimes/rarely/never), practice was considered routine if respondents 206 
selected the ‘always’ or ‘often’ options. The statistical significance of the difference 207 
between two proportions was calculated using McNemar’s test (McNemar, 1947). 208 
 209 
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Results  210 
Nineteen of the twenty centres contributed to the survey resulting in a centre response rate 211 
of 95%. Complete responses were received from 33 individual audiologists, representing an 212 
estimated individual response rate of 50% based on the number of registered BCIG 213 
members with audiology-related job titles. The centres that chose to participate and the 214 
numbers of completed surveys received from each are shown in Table 1. As the number of 215 
responses differed across centres, the interpretation of the results was based on summary 216 
statistics of responses at the centre level, rather than at the individual level. A further five 217 
respondents completed part of the survey but did not identify which centre they practiced 218 
at. Their responses were included when calculating summary statistics at the individual 219 
level. 220 
 221 
Section 1: Current clinical practice in the UK  222 
The proportion of centres who indicated undertaking activities in various parts of the care 223 
pathway and the associated confidence intervals are listed in Tables 2 and 3. 224 
 225 
(a) Hearing aid management during candidacy assessment (Table 2) 226 
Respondents estimated that 87% of patients who attend for candidacy assessment wear a 227 
HA in at least one ear (95% confidence interval: 83-92%). All but one centre reported that 228 
they do conduct HA evaluations as part of the candidacy assessment and a majority of those 229 
centres (14 out of 18) reported checking HA fittings routinely as part of this evaluation.  The 230 
fact that some respondents in those 14 centres indicated that they do not check HA fittings 231 
routinely could suggest some level of inconsistency within centres but may also simply 232 
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reflect the division of responsibilities among staff. Eleven centres indicated that they would 233 
check the HA fitting in every patient who attended wearing HAs, but this did not represent a 234 
majority.  235 
 236 
The need for HA fitting and evaluation appeared to be judged on an individual basis. When 237 
presented with the scenario of a CI candidate who does not wear HAs but has measurable 238 
hearing thresholds or a history of recent HA usage, a majority of centres (83%) indicated 239 
they would routinely attempt to fit HAs. When presented with an alternative scenario of a 240 
candidate attending wearing a single HA, the number of centres that reported routinely 241 
attempting a HA fitting in the unaided ear dropped to 61%, which did not represent a 242 
majority. Two respondents from a single CI centre commented that they would rarely 243 
attempt to fit a HA to the unaided ear as the result would be unlikely to affect the candidacy 244 
decision, where open-set speech discrimination scores in the quiet when in their best-aided 245 
condition must be <50% (NICE, 2009). 246 
 247 
A variety of HA fitting and verification methods were reported including fitting to a 248 
prescription target (64%), Real Ear Measurement (61%), aided threshold measurement 249 
(50%) and speech discrimination testing (50%). The majority of centres reported using a 250 
combination of methods.  251 
 252 
(b) Hearing aid management following implantation (Table 2) 253 
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Respondents estimated that 58% of patients who received their CI within the last 5 years 254 
wear a contralateral HA at initial activation of the CI (95% confidence interval: 51-64%), but 255 
hypothesised that only 41% of this group would still be wearing the HA after 5 years of 256 
implant use (mean decrease as a proportion of all CI users of 33%; 95% confidence interval 257 
28-38%). Only a minority of centres indicated that they take full responsibility for the 258 
maintenance of the contralateral HA once the CI is activated despite the fact that the 259 
majority of centres reported routinely conducting HA reassessments prior to implantation, 260 
and may have fitted the aid during the assessment. Instead, a majority of centres indicated 261 
that they refer patients elsewhere for their ongoing hearing aid maintenance, usually the 262 
implant user’s local audiology team, who may or may not have fitted the HA originally. 263 
 264 
A minority of centres indicated that they routinely conduct a contralateral HA evaluation 265 
within the first 12 months of CI use, and only 3 centres reported routinely reviewing the HA 266 
fitting after 12 months of CI use. Six centres indicated that they would attempt to re-fit a 267 
contralateral HA that a CI user had stopped wearing following implantation but this 268 
represented a minority view. All centres indicated that they would not routinely fit a new 269 
HA in an unaided contralateral ear within the first 3 months after CI activation, even if it had 270 
potentially aidable thresholds, although nine centres indicated that they would consider it 271 
but only at the patient’s request. The post-operative HA fitting and verification methods 272 
reported by respondents were notably different to the methods chosen pre-operatively, 273 
with only 33% of respondents selecting the same combination of methods at the two time 274 
intervals.  275 
 276 
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(c) Sympathetic bimodal fitting (Table 3) 277 
At initial CI activation, only one centre reported an agreed protocol for “bimodal switch-on” 278 
in the clinic; i.e. consideration of both devices when creating the first CI programme. Four 279 
centres did report taking the HA parameters into account when first activating the CI, but no 280 
centre indicated making any attempt to match device parameters such as compression 281 
settings or frequency allocations at this stage. Eleven centres reported attempting to match 282 
the two devices for loudness at the CI fitting stage but this did not represent a majority. 283 
 284 
There was minimal evidence that devices are fit sympathetically at subsequent CI review 285 
appointments. Only one centre, which notably was not the centre that reported using a 286 
bimodal switch-on procedure above, reported following a protocol for programming 287 
bimodal patients in the clinic. Only a minority of centres reported taking the parameters of 288 
the HA into account when deciding how to reprogramme the CI, and only one respondent 289 
was consistent in using these parameters at both switch-on and subsequent reviews. Only 290 
two centres indicated that they attempt to match device parameters such as compression 291 
settings or frequency allocations at CI review appointments. However, a majority of centres 292 
reported balancing loudness across the two devices at review appointments. 293 
 294 
In summary, inconsistencies in practices relating to bimodal fitting at both initial and 295 
subsequent CI programming appointments were apparent. It would therefore appear likely 296 
that any programming adjustments related to improving bimodal listening are made to the 297 
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implant only and not to the HA, given that the majority of centres do not routinely adjust HA 298 
fittings post-implantation. 299 
 300 
(d) Bimodal outcome measurement (Table 3) 301 
When a bimodal listener attends for a performance review, all but one centre reported 302 
routinely measuring listening outcomes using the CI alone, 12 centres (not a majority) 303 
reported routinely measuring bimodal listening outcomes, while a minority of centres 304 
reported routinely measuring outcomes from the HA alone following implantation.  Only 305 
seven centres reported that they follow an agreed protocol for measuring bimodal benefit 306 
in the clinic, and three centres reported rarely or never measuring bimodal outcomes.  307 
 308 
Of the 12 centres that report measuring bimodal outcomes routinely, four indicated that 309 
they choose additional listening tests specifically to measure bimodal benefit that would not 310 
normally be used with a unilateral CI listener. A free text box was provided for respondents 311 
to list any test used specifically to measure bimodal benefit. The following tests were listed: 312 
BKB sentences in adaptive noise test, the Star2 (Sentence Test with Adaptive Randomised 313 
Roving levels) test (Joffo and Boyle, 2010), multiple speaker sound localisation, and the CRM 314 
(Coordinate Response Measure) sentence test (Kitterick et al., 2010, Kitterick et al., 2011).  315 
 316 
(e) Patient advice (Table 3)       317 
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When a patient attends for initial activation wearing a HA in the non-implanted ear, advice 318 
about how to use the HA in addition to the CI was inconsistent across centres. Only a 319 
minority of centres recommend that both devices be worn together from the first day that 320 
the CI is activated, with 68% recommending intermittent use of the HA at first to allow time 321 
for CI-only listening.  A separate minority reported advising patients not to wear the HA until 322 
they have been using their CI for around 3 months. Four centres indicated that they would 323 
not make recommendations about contralateral HA use and would leave it to the patient to 324 
decide.  325 
 326 
In spite of the uncertainties about HA use evident at initial CI activation, a majority of 327 
centres (95%) reported actively encouraging CI users to wear a contralateral HA once they 328 
had used their implant for at least 3 months. No respondent reported actively discouraging 329 
contralateral HA usage after an initial 3-month CI acclimatisation period. 330 
 331 
Interim summary 332 
An overview of the consistencies and inconsistencies of clinical practice derived from this 333 
section is shown in Table 4. Centres almost universally reported evaluating HAs during 334 
candidacy assessment, a practice that is consistent with national guidance that requires the 335 
speech perception abilities of candidates to be assessed in the best-aided condition (NICE, 336 
2009). However, some variability in reported practice both within and between centres was 337 
apparent. The current reports suggest that most centres do not maintain the long term care 338 
of the contralateral HA, do not routinely optimise bimodal aiding through evaluating or re-339 
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fitting the HA post-operatively, and do not practise sympathetic bimodal fitting. The focus of 340 
the audiologist seems primarily on optimising the CI. The two devices are therefore likely to 341 
be programmed independently after implantation, on separate occasions and not 342 
necessarily by the same person or at the same centre.  Whilst there is reportedly some 343 
uncertainty about how to advise patients on bimodal listening at initial CI activation, most 344 
centres appear to actively encourage HA during later stages of CI use, implying a mismatch 345 
between their advice to listen bimodally and their clinical practice to optimise it.  346 
 347 
Section 2: Factors limiting bimodal practice 348 
Table 5 lists the proportion of CI centres and individual responses who agreed or disagreed 349 
with statements about factors that might limit the provision and optimisation of bimodal 350 
devices and their associated confidence intervals.  351 
 352 
(a) Hearing aid management  353 
A minority of centres indicated that a lack of time, rooms and equipment are significant 354 
factors limiting HA management during candidacy assessment. Six centres reported a 355 
shortage of available audiologists, and eight reported a lack of staff expertise in HA fittings. 356 
Only one centre suggested that insufficient residual hearing was a factor limiting HA fitting 357 
during candidacy assessment, which represented a minority view.  358 
 359 
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Three centres had at least one respondent report that they do not evaluate HAs as part of 360 
the candidacy assessment. The most frequent limiting factors cited by these respondents 361 
were a lack of staff expertise (3 centres), insufficient numbers of audiologists (3 centres) and 362 
a lack of rooms/equipment (2 centres). None of these centres indicated that time was a 363 
limiting factor. Further free text comments suggested that a lack of funding for HA provision 364 
at CI centres may be a contributing factor to the lack of HA evaluations during candidacy 365 
assessment.  366 
 367 
During the initial CI activation period, a minority of centres indicated that lack of equipment 368 
was a limiting factor but 68% indicated that there was insufficient time to evaluate HAs in 369 
addition to the CI. The role of time, equipment, staffing or staff expertise in limiting HA 370 
management during subsequent routine CI review appointments were all listed as limiting 371 
factors, but were variable across centres suggesting that there is no single factor that 372 
presents a consistent barrier to the provision of bimodal aiding in established CI users. 373 
 374 
(b) Bimodal outcome measurement  375 
A minority of centres indicated that there is a lack of staff expertise within their centres to 376 
measure bimodal outcomes. Nine centres reported insufficient time to measure bimodal 377 
listening outcomes in addition to CI-only, and six centres reported insufficient equipment. 378 
 379 
(c) Sympathetic bimodal fitting  380 
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Around half of all centres (58%) indicated that there is insufficient time to conduct 381 
sympathetic fitting of both devices in the same session. A similar number of centres agreed 382 
that there is a lack of guidance on how to optimise the two devices to work better together. 383 
Additionally, the fact that only a minority of centres reportedly retain responsibility for 384 
ongoing care of the contralateral HA post-implantation (Table 2) may also represent a 385 
significant factor limiting the provision of sympathetic bimodal fitting.  386 
 387 
Interim summary 388 
The pattern of responses suggests that in centres that currently undertake HA evaluations, 389 
resources for managing HAs both during candidacy assessment and after implantation are 390 
adequate. In centres that do not currently undertake HA evaluations as part of their service, 391 
there appear to be more limitations to overcome including lack of staff expertise, facilities, 392 
and possibly also a lack of funding. The fact that respondents from these centres indicated 393 
that time is not a limitation suggests that routine HA evaluations would be possible if these 394 
logistical factors were addressed. Measurements of bimodal outcomes would also appear to 395 
be feasible given the available resources and staff expertise reported by respondents, but 396 
longer review appointments may be necessary to ensure that they can be obtained 397 
consistently across all patients and centres. The sympathetic fitting of the CI and HA does 398 
not appear to be feasible at present due to the time constraints and lack of experience and 399 
guidance reported by respondents. Therefore, the data suggest that additional time may 400 
also be necessary during certain appointments to ensure that the HA and CI can be 401 
maintained and optimised at the same time. 402 
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  403 
Section 3: Respondent views regarding bimodal issues 404 
Table 6 lists the proportion of CI centres and individual respondents who expressed 405 
agreement with a range of statements about bimodal aiding and the associated confidence 406 
intervals. 407 
 408 
(a) Hearing aid management  409 
A majority of centres (95%) indicated that it is beneficial both to attempt to optimise HAs 410 
during the candidacy assessment stage and to optimise the contralateral HA post-411 
implantation.  A majority of centres were also of the opinion that HA optimisation was 412 
within the role of the CI audiologist both during candidacy assessment and post-operatively 413 
(68% and 79%, respectively). Responses from individual audiologists about whether they 414 
feel it is within their role to evaluate HA fittings were more mixed both when considering 415 
candidacy assessment (42%) and post-operative appointments (61%). It is possible that this 416 
apparent variability within centres may have reflected the division of responsibilities among 417 
staff. 418 
 419 
Respondents were invited to comment on the practicalities of maintaining both devices. 420 
Common themes in the responses to this open-ended question indicated that:  (i) managing 421 
both devices may provide a smoother service for the patient throughout the care pathway; 422 
(ii) there are logistical difficulties around HA maintenance as many patients do not live near 423 
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their CI centre and may prefer to access HA repair services locally; (iii) there are difficulties 424 
with funding as CI services may not be commissioned to support and manage HAs; and (iv) 425 
there is limited staff expertise of the range of available HAs, software, stock, and spares 426 
within CI centres. 427 
 428 
(b) Bimodal benefit  429 
When asked to consider both the positives and the negatives of contralateral HA use, the 430 
majority of centres (84%) agreed that bimodal aiding provides more benefit than wearing 431 
the CI alone. No respondent indicated that wearing the CI alone was more beneficial than 432 
bimodal aiding. The majority of centres (84%) reported taking the possibility of bimodal 433 
aiding into consideration when choosing which ear to implant, although at an individual 434 
level 64% of respondents reported doing so, which did not represent a majority. 435 
Respondents were asked to list up to three potential advantages and three potential 436 
disadvantages of wearing a contralateral HA in addition to a CI that they had directly 437 
observed or heard from patients during their clinical practice. Figure 1 shows the reported 438 
categories of bimodal advantage, the largest of which was sound localisation. Figure 2 439 
shows the reported categories of bimodal disadvantage, the largest of which was related to 440 
wearing an earmould. 441 
 442 
In spite of the majority of clinics not having an agreed protocol for measuring bimodal 443 
outcomes (Section 1d), the majority of centres (95%) reported that it is clinically useful to 444 
measure bimodal benefit. Respondents were asked to rate the most useful outcome 445 
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measures to demonstrate bimodal benefit and the proportion of respondents who selected 446 
each category of test is shown in Figure 3. A majority of respondents indicated that 447 
measuring speech discrimination in background noise was the most useful clinical measure 448 
of bimodal benefit.  449 
 450 
(c) Sympathetic bimodal fitting  451 
When asked to compare sympathetic with independent bimodal device fittings, a majority 452 
of centres (84%) felt that fitting the devices sympathetically (taking into account each 453 
other’s settings) could somehow improve bimodal outcomes over fitting the two devices 454 
independently. A majority (79%) also rated a recently-refit contralateral HA as more 455 
beneficial than one that has not been recently re-fit. However, 84% of centres 456 
acknowledged that wearing a contralateral HA that was fit prior to receiving the CI may be 457 
sufficient to provide some bimodal benefits. Thus, the responses imply that the use of a 458 
contralateral HA, and not necessarily one that has been recently optimised, is better than 459 
not using a HA at all. 460 
 461 
(d) Further guidance  462 
Respondents from 18 centres completed this section. Every centre indicated that they 463 
would welcome guidance on: (1) how to maximise bimodal benefit; (2) how to optimise 464 
bimodal fitting; (3) which patients would be most likely to benefit from a contralateral HA 465 
fitting; (4) measuring bimodal benefit; and (5) how to advise patients about being a bimodal 466 
listener. A majority of respondents (83%) were unsure as to the best time to reintroduce a 467 
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HA following CI activation, presumably attributable to concerns about CI acclimatisation 468 
discussed previously.  469 
 470 
Interim summary 471 
Respondents indicated that it may be in the best interests of the patient to have both 472 
devices managed by a single centre but acknowledged the practical limitations of this 473 
model. The general view that the optimisation of HA fittings following implantation is within 474 
the role of the CI audiologist appeared to suggest that what respondents reported as being 475 
their current practice is not always able to reflect what they believe to be optimal for the 476 
patient. Bimodal aiding was viewed as potentially more advantageous to the patient than 477 
wearing the CI alone, and sympathetic bimodal fitting was also viewed more favourably 478 
than devices that had not been sympathetically fit. Bimodal outcome measurements appear 479 
to be considered clinically useful, although it is unclear if and how these measurements 480 
inform HA optimisation. Respondents acknowledged that further guidance on aspects of 481 
bimodal fitting is required to implement changes in routine fitting practice.  482 
 483 
Discussion 484 
A survey of CI audiologists across the UK characterised their reported clinical practice 485 
around bimodal aiding, identified factors that may be limiting the provision of bimodal 486 
aiding, ascertained their views on bimodal aiding, and demonstrated consistencies and 487 
inconsistencies in practice across the UK. 488 
 489 
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Changing candidacy landscape 490 
Until relatively recently, few individuals with useful residual hearing in the contralateral ear 491 
received a CI in the UK. A large-scale UK study that collated outcomes from adults implanted 492 
between 1998 and 2000 demonstrated that most were unable to derive benefit from 493 
acoustic amplification pre-operatively (UKCISG, 2004a). Even candidates who had some 494 
measurable speech understanding using HAs (‘marginal HA users’) were receiving only 495 
minimal benefit from amplification in their better ear and had an average open-set speech 496 
discrimination score of only 13%. Respondents to the current survey estimated that 497 
approximately half of those implanted within the last five years will continue to wear a HA 498 
even after their CI is activated, suggesting that contemporary CI recipients may receive 499 
additional benefits from contralateral acoustic amplification. This estimate is compatible 500 
with the results of a recent survey of CI users, which found that 48% of respondents who 501 
had been implanted in the UK in the five years between 2010-2015 reported using a 502 
contralateral HA (Fielden et al., 2016a).  It would therefore appear as if there has been an 503 
increase in the number of CI candidates who have aidable residual hearing since both the 504 
last UK-wide outcomes study and the publication of NICE guidance (NICE, 2009). 505 
 506 
One impact of this change in who is receiving cochlear implants in the UK is that a large 507 
proportion of recipients may no longer be monaural listeners whose outcomes are 508 
determined solely by a single implanted ear as was previously the case, but rather binaural 509 
listeners who may derive benefits from the combination of the CI and the HA. In these 510 
patients, CI audiologists have had to shift their focus away from considering an outcome 511 
solely in terms of a patient’s capacity to use their CI and towards an outcome based on 512 
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binaural listening. However, this apparent change in practice has occurred in the absence of 513 
any guidance or training and is therefore likely to be based predominantly upon clinical 514 
experience. The disconnect apparent in the survey between the role of audiologists working 515 
in CI centres today and the evidence available to them with which to inform their practice 516 
may explain why the current provision of bimodal aiding appears to be inconsistent and at 517 
odds with the views of those who deliver it.  518 
 519 
Estimates of sustained bimodal usage 520 
While audiologists in the survey estimated that approximately half of those implanted 521 
within the last five years will wear a HA at activation, they also estimated that less than half 522 
of these patients will continue to wear their HA once they have used their implant for a 523 
further five years. This estimate of the proportion of longer-term bimodal users contrasts 524 
with previous estimates that have assumed a constant proportion of around 70% of implant 525 
recipients (Bond et al., 2009). The reasons for the estimated drop in the number of bimodal 526 
users over time are unclear, but at least five plausible explanations are apparent. First, the 527 
bimodal benefit perceived by the patient may lessen as they become more proficient at 528 
listening using the CI. Second, the amount of residual hearing may be so marginal that the 529 
natural progression of the hearing loss over time may reduce HA benefit leading to eventual 530 
non-use, perhaps because the better-hearing ear was selected for implantation. Third, the 531 
independent fitting of both devices may mean that some patients struggle to integrate the 532 
electric and acoustic signals and eventually stop using the HA. Fourth, as HAs are not 533 
typically maintained by CI centres there is a lack of cohesion between hearing services, and 534 
the bimodal patient may receive conflicting advice at each service or find it impractical to 535 
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access HA maintenance services over time. Finally, it is possible that only a small proportion 536 
of UK CI users can obtain consistent and useful bimodal benefits in spite of the previous four 537 
issues, and are therefore the ones to persist with contralateral HA usage. It is impossible to 538 
know which of these, if any, could potentially contribute to poor rates of sustained HA use. 539 
More research is needed to isolate the reasons that could contribute to non-use of 540 
contralateral HAs and to provide more direct evidence for the number and nature of 541 
patients who could receive ongoing bimodal benefits. 542 
 543 
Nature of bimodal benefit 544 
While the majority of audiologists agreed that bimodal aiding can be beneficial and 545 
encourage patients to wear a contralateral HA, the survey highlighted some uncertainty 546 
around best practice. For example, uncertainty was evident about who could benefit from 547 
bimodal aiding, when to introduce the HA after CI activation and how to fit devices 548 
sympathetically. This uncertainty may be a result of the limited available evidence for what 549 
aspects of hearing status determine the degree of bimodal benefit available to the patient. 550 
A systematic review of the effectiveness for cochlear implantation as a treatment for 551 
severe-profound deafness found that studies comparing bimodal aiding with unilateral CI or 552 
bilateral CI were poor in quality and low in number (Bond et al., 2009). To date, there is a 553 
lack of agreement in the literature as to what aspects of the HA signal delivery contribute to 554 
bimodal benefit with the possibilities including access to low frequency acoustic cues (Zhang 555 
et al., 2010), spectral modulation detection (Zhang et al., 2013), or how effectively the 556 
modalities integrate (Yoon et al., 2015). Notably, these and other studies that have 557 
demonstrated bimodal benefit have been conducted almost exclusively on patients 558 
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implanted outside the UK who have greater levels of residual hearing in the non-implanted 559 
ear than are typically accessible to UK patients. Therefore, further research on UK patients is 560 
needed to ascertain whether similar benefits are possible given the current candidacy 561 
criteria. However, even if the benefits can be realised there appears to be both a lack of 562 
consistency for how to identify who may benefit from bimodal aiding and how to optimise 563 
bimodal devices to maximise benefit.  564 
 565 
Influence on the choice of ear to implant 566 
Responses to the present survey suggest that audiologists are considering the potential 567 
benefits from preserving patients’ access to residual acoustic hearing when recommending 568 
which ear to implant in at least some patients. Compatibly, a recent hypothetical decision-569 
choice experiment suggested that clinicians may not always advise implanting the ‘optimal’ 570 
ear for CI outcomes in order to preserve residual hearing where possible (Fielden et al., 571 
2016b). Given that little would be gained if residual hearing was preserved by 572 
recommending a physiologically-unresponsive ear for implantation, their willingness to 573 
consider residual hearing may suggest that centres are now seeing more patients in whom 574 
both ears are receptive to implantation; i.e. are likely to improve performance if implanted. 575 
The results may therefore suggest that audiologists are now able to be increasingly cautious 576 
about risking the loss of residual hearing in patients where the choice of ear is not strongly 577 
influenced by other factors. However, it remains unclear to what extent factors relating to 578 
residual hearing inform decision making around which ear to implant, how frequently, and 579 
in what proportion of patients. As the present results suggest that audiologists’ practice 580 
remains focused on maximising outcome using the CI alone, it is likely that the choice of ear 581 
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is still influenced primarily by factors such as the physiological responsiveness and duration 582 
of deafness of each ear, which can be used to estimate the likelihood that implanting a 583 
particular ear will improve performance compared to the best-aided condition using HAs 584 
alone (UKCISG, 2004b). 585 
 586 
Commissioning arrangements 587 
The disconnect between the apparent willingness of the respondents to encourage bimodal 588 
aiding and the fact that services related to bimodal aiding are reportedly rarely provided 589 
may be attributable, at least in part, to the manner in which implantation services are 590 
commissioned in the UK. The guidance from NICE which informs current commissioning 591 
arrangements was based on an assessment of the effectiveness and cost-effectiveness of 592 
cochlear implantation in the UK that compared acoustic hearing aids to the provision of 593 
either unilateral implantation or bilateral implantation (Bond et al., 2009). While the 594 
economic evaluation did account for the fact that a subset of patients continue to use a HA 595 
following cochlear implantation and therefore incur additional costs to the health service, 596 
the evaluation did not assume any incremental benefit arising from the provision of a well-597 
fit acoustic hearing aid in the non-implanted ear. The decision to not account for any 598 
bimodal benefit was based primarily on the lack of robust evidence for the impact that 599 
bimodal aiding has on the overall health and well-being of patients. In the absence of such 600 
evidence in UK patients and therefore evidence for the cost-effectiveness of bimodal aiding, 601 
it is unlikely that funding arrangements will change to include maintenance provision of two 602 
devices in those patients who may benefit from their use. 603 
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 604 
Practical considerations 605 
The survey highlighted practical problems that would arise if a single service were to 606 
maintain both devices with respondents identifying issues related to staff time and funding 607 
as potential limiting factors. While an integrated model of service provision would likely 608 
provide a smoother service for the patient, create a more cohesive care pathway, and 609 
facilitate the sympathetic optimisation of the two devices, it may also be less convenient for 610 
the patient who may have to travel many miles to reach their nearest CI centre for minor 611 
adjustments to the HA or to obtain replacement parts. A more practical arrangement could 612 
be for the CI centre to take responsibility only for the fitting and reprogramming of HAs, 613 
while routine maintenance and spare parts continued to be provided by local audiology 614 
departments. A more radical approach would be for certain aspects of CI care to be 615 
undertaken by local audiology departments, perhaps with remote assistance from the CI 616 
centre. However, this approach would currently not meet the standard for quality of care as 617 
specified in the BCIG quality standards report (NICE 2007). This option would therefore 618 
require considerable investment to ensure that remote standards of care were achieved.  619 
Another option that is already being explored by CI centres nationally is the adoption of 620 
outreach clinics, which could be extended to support bimodal fittings. 621 
 622 
Given the increasing numbers of CI users requiring ongoing maintenance and the numbers 623 
of patients who could now be aided bimodally, changes to the current model of service 624 
provision would appear to be inevitable. Audiologists generally appear to be willing to 625 
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consider changes in their practice to enhance the provision of bimodal aiding, but the lack of 626 
evidence with which to inform their practice and practical issues related to time and funding 627 
severely limit the nature and scope of any changes that could be made at the present time. 628 
 629 
Recommendations for future research 630 
This survey has demonstrated that UK audiologists are willing to consider changing their 631 
practice relating to bimodal aiding but have identified a need for guidance on best practice 632 
regarding: (a) the fitting and evaluation of HAs during candidacy assessment; (b) identifying 633 
who is likely to benefit from bimodal aiding; (c) providing advice on HA use at CI switch-on; 634 
(d) optimising bimodal aiding (including sympathetic bimodal fitting); and (e) using bimodal 635 
outcome measurement to both inform fitting and monitor changes in performance. The 636 
creation of guidance on these topics is currently hindered by a lack of evidence for the size 637 
and nature of bimodal benefits that are available to UK CI users and evidence for whether 638 
the methodologies that have been proposed for optimising the fitting of bimodal devices 639 
are applicable to clinical practice in the UK. 640 
 641 
At the very least, the development of new guidance would require: (a) an up-to-date 642 
systematic review of the evidence for the effectiveness of bimodal aiding that includes 643 
patients with limited residual hearing similar to that of UK patients; (b) evidence that the 644 
provision of bimodal aiding is a cost-effective use of limited NHS resources; (c) evidence that 645 
existing bimodal fitting and assessment methods are appropriate for use UK patients; and 646 
(d) a consensus among clinicians on those aspects of bimodal fitting that are feasible to 647 
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implement and of benefit to patients. While the current survey has identified some aspects 648 
of practice and views that appear to be held consistently across UK CI centres, any 649 
consensus exercise to inform guidance would ideally be formed using an established 650 
methodology such as a Delphi process (Dalkey, 1969) and involve the broad range of 651 
healthcare professionals that deliver the current care pathway. Further research should also 652 
engage with UK CI recipients whose experience can contribute to a better understanding of 653 
the benefits and disadvantages of bimodal aiding, and why patients choose to use or not to 654 
use a contralateral HA. 655 
 656 
Ultimately, an evaluation of the benefits that bimodal aiding provides to UK patients should 657 
be based on well-designed clinical controlled trials. It is only when such robust evidence is 658 
available that current clinical commissioning arrangements are likely to be amended to both 659 
recommend and fund bimodal aiding in the UK. 660 
  661 
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Figure Captions 761 
Figure 1. Categories of bimodal advantages reported by respondents from direct 762 
observation of patients. Error bars plot 95% confidence intervals. A proportion whose right 763 
error bar is entirely to the left of the 50% line demonstrates an observation that was 764 
observed only by a minority of respondents, whereas a proportion whose left error bar is 765 
entirely to the right of the 50% line represents the majority of respondents. 766 
 767 
Figure 2. Categories of bimodal disadvantages reported by respondents from direct 768 
observation of patients. Error bars plot 95% confidence intervals. A proportion whose right 769 
error bar is entirely to the left of the 50% line demonstrates an observation that was 770 
observed only by a minority of respondents, whereas a proportion whose left error bar is 771 
entirely to the right of the 50% line represents the majority of respondents. 772 
 773 
Figure 3. Outcome measures reported as being clinically useful in demonstrating benefit in 774 
bimodal listeners. Error bars plot 95% confidence intervals. A proportion whose right error 775 
bar is entirely to the left of the 50% line demonstrates an observation that was observed 776 
only by a minority of respondents, whereas a proportion whose left error bar is entirely to 777 
the right of the 50% line represents the majority of respondents. 778 
 779 
 780 
 781 
 782 
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Table captions 783 
TABLE 1.  A list of the UK adult cochlear implant centres which contributed to the survey 784 
dataset and the numbers of respondents from each. The 19 participating centres represents 785 
a response rate of 95%. The UK centre not listed either did not participate in the survey or 786 
did not complete the survey to the point where the centre name was requested. 787 
 788 
TABLE 2. Mean responses to questions about current clinical practice in the UK relating to 789 
HA management. The number of CI centres from which positive responses were received to 790 
each question is reported together with the percentage and its 95% confidence interval. The 791 
table also lists the number of respondents who responded positively, also expressed as a 792 
percentage with 95% confidence intervals. The use of bold type indicates that a result 793 
represented a significant minority (<50%) or majority (>50%) of CI centres and/or 794 
respondents. 795 
 796 
TABLE 3. Mean responses to questions about current clinical practice in the UK relating to 797 
bimodal fitting, outcome measurement, and advice. The number of CI centres from which 798 
positive responses were received to each question is reported together with the percentage 799 
and its 95% confidence interval. The table also lists the number of respondents who 800 
responded positively, also expressed as a percentage with 95% confidence intervals. The use 801 
of bold type indicates that a result represented a significant minority (<50%) or majority 802 
(>50%) of CI centres and/or respondents. 803 
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 804 
TABLE 4. A summary of clinical practice at different stages of the temporal clinical care 805 
pathway. A tick represents practice that is routine, i.e. conducted by a majority of 806 
respondents and centres; a cross represents practice that is not routine, i.e. conducted only 807 
by a minority of respondents and centres, and a question mark represents inconsistency in 808 
practice across respondents and centres. The table numbers that contain these data are 809 
shown in brackets. 810 
 811 
TABLE 5. Mean responses to questions about factors that limit clinical practice in the UK 812 
relating to bimodal aiding. The number of CI centres from which positive responses were 813 
received to each question is reported together with the percentage and its 95% confidence 814 
interval. The table also lists the number of respondents who responded positively, also 815 
expressed as a percentage with 95% confidence intervals. The use of bold type indicates 816 
that a result represented a significant minority (<50%) or majority (>50%) of CI centres 817 
and/or respondents. 818 
 819 
TABLE 6. Mean responses to questions about audiologists’ views of bimodal aiding. The 820 
number of CI centres from which positive responses were received to each question is 821 
reported together with the percentage and its 95% confidence interval. The table also lists 822 
the number of respondents who responded positively, also expressed as a percentage with 823 
95% confidence intervals. The use of bold type indicates that a result represented a 824 
significant minority (<50%) or majority (>50%) of CI centres and/or respondents. 825 
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 826 
 827 
 828 
 Figure 1 
  
 Figure 2 
  
 Figure 3 
 Participating Centres Number of 
responses 
Belfast Cochlear Implant Centre 1 
Cardiff Adult Cochlear Implant Programme 1 
Dublin Cochlear Implant Programme 1 
Emmeline Centre, Cambridge 1 
The Richard Ramsden Centre for Hearing Implants (Manchester) 3 
The Midlands Hearing Implant Programme (Adults’ Service) 3 
North Wales Cochlear Implant Programme 1 
Nottingham Auditory Implant Programme 3 
The Oxford Cochlear Implant Programme 
Portland Hospital Cochlear Implant Programme 
1 
1 
RNTNE Adult Implant Programme 1 
Scottish Cochlear Implant Programme 
South Wales Cochlear Implant Programme, Bridgend 
2 
1 
St George’s Hospital Auditory Implant Service 1 
St Thomas’ Hospital Hearing Implant Centre 1 
University of Southampton Auditory Implant Service 7 
West of England Hearing Implant Programme 2 
Yorkshire Auditory Implant Service (Bradford) 1 
Yorkshire Auditory Implant Service (Sheffield) 1 
Total number of completed responses (with identifiable affiliation) 33 
Total number of incomplete responses (without identifiable affiliation) 5 
Total number of responses 38 
 
  No.  
centres 
(%; 95% CI) 
No. 
respondents 
(%; 95% CI) 
HA management during candidacy assessment  (Section 1a)   
Numbers who…   
conduct HA evaluations as part of the candidacy assessment 18 (95; 75-99) 28 (74; 58-85) 
routinely check HA fittings in patients attending for assessment 
check HA fittings in every HA user during assessment 
14 (78; 55-91) 
11 (61; 39-80) 
21 (75; 57-87) 
16 (57; 39-73) 
routinely attempt a HA fitting in a candidate with no HAs 15 (83; 61-94) 24 (86; 69-94) 
routinely attempt to fit a HA to a single non-aided ear 11 (61; 39-80) 14 (50; 33-67) 
use a combination of HA evaluation methods 17 (94; 74-99) 23 (82; 64-92) 
HA management following implantation (Section 1b)   
Numbers who…   
routinely take responsibility for the contralateral HA  5 (26; 12-49)  6 (18; 9-34) 
would refer to a different audiologist for HA issues 15 (79; 57-91) 27 (82; 66-91) 
evaluate the contralateral HA during the first 12m of CI use  8 (42; 23-64) 10 (30; 17-47) 
attempt to re-fit a HA the patient had stopped wearing              6 (32; 15-54)  6 (18; 9-34) 
routinely attempt a HA fitting in an unaided contralateral ear  0 (0; 0-17)  0 (0; 0-10) 
only fit a HA to an unaided contralateral ear at patient request       9 (47; 27-68) 10 (30; 17-47) 
routinely review the HA fitting after 12m of CI use   3 (16; 6-38)  3 (9; 3-24) 
use the same combination of HA evaluation methods as pre-CI  9 (47; 27-68) 10 (33; 19-51) 
 
  No. 
centres 
(%; 95%CI) 
No. 
respondents 
(%; 95%CI) 
Sympathetic bimodal fitting (Section 1c)   
At initial activation:  Numbers who… 
follow an agreed bimodal switch-on protocol  
  
1 (5; 1-25) 
  
1 (3; 1-15) 
take HA parameters into account when programming the CI  4 (21; 9-43)  4 (12; 5-27) 
match fitting parameters e.g. frequency ranges of HA and CI  0 (0; 0-17)  0 (0; 0-10) 
balance the CI and HA for loudness  11 (58; 36-77) 12 (36; 22-53) 
At subsequent review appointments: Numbers who…   
follow an agreed bimodal programming protocol   1 (5; 1-25)  2 (6; 2-20) 
take HA parameters into account when programming the CI  3 (16; 6-38)  3 (9; 3-24) 
match fitting parameters e.g. frequency ranges of HA and CI   2 (11; 3-31)  3 (9; 3-24) 
balance the CI and HA for loudness  15 (79; 57-91) 18 (55; 38-70) 
Post-implant bimodal outcome measurement (Section 1d)   
Numbers who…   
follow an agreed protocol for measuring bimodal benefit  7 (37; 19-59)  8 (24; 13-41) 
routinely measure CI-only listening outcomes  18 (95; 75-99) 27 (82; 66-91) 
routinely measure bimodal listening outcomes  12 (63; 41-81) 17 (52; 35-67) 
routinely measure HA-only listening outcomes  5 (26; 12-49)  5 (15; 7-31) 
choose specific outcome measures to measure bimodal benefit  4 (33; 14-61)  4 (24; 10-47) 
Advice given to patients (Section 1e)   
At initial activation:  Numbers who…   
recommend intermittent use of the HA at first  13 (68; 46-85) 19 (58; 41-73) 
recommend not wearing the HA until 3 months post-CI   4 (21; 9-43)  5 (15; 7-31) 
recommend both devices be worn together from the start  3 (16; 6-38)  5 (15; 7-31) 
leave it to the patient to decide if bimodal aiding is beneficial  4 (21; 9-43)  4 (12; 5-27) 
At subsequent review appointments: Numbers who…   
actively encourage established CI users to wear a HA 18 (95; 75-99) 31 (94; 80-98) 
 
 Practice Pre-implant Initial 
activation 
Post-implant 
Hearing aid management  (2)  (2)  (2) 
Sympathetic bimodal fitting  --  (3)  (3) 
Advice to patients on bimodal aiding  --  ?   (3)  (3) 
Bimodal outcome measurement  --  --  ?   (3) 
 
 
 No. 
centres 
(%; 95%CI) 
No. 
respondents 
(%; 95%CI) 
HA management (Section 2a)   
During candidacy assessment.  Numbers who indicated…   
a lack of staff expertise in HA fitting  8 (42; 23-64) 18 (50; 34-66) 
a lack of time  3 (16; 6-38)  4 (11; 4-25) 
a lack of available audiologists  6 (32; 15-54)  8 (22; 12-38) 
a lack of rooms/equipment   5 (26; 12-49)  9 (25; 14-41) 
patients have insufficient residual hearing  1 (5; 1-25)  1 (3; 0-14) 
During initial activation. Numbers who indicated…   
a lack of time 13 (68; 46-85) 17 (52; 35-67) 
a lack of equipment  5 (26; 12-49) 10 (30; 10-47) 
During subsequent reviews. Numbers who indicated…   
a lack of  time 11 (58; 36-77) 15 (45; 30-62) 
a lack of rooms/equipment  7 (37; 19-59) 11 (33; 20-50) 
a lack of staff expertise in HA fitting  5 (26; 12-49) 14 (42; 27-59) 
a lack of available audiologists  9 (47; 27-68) 18 (55; 38-70) 
Bimodal outcome measurement (Section 2b)   
Numbers who indicated…   
a lack of time  9 (47; 27-68) 12 (36; 22-53) 
a lack of staff expertise  4 (21; 9-43)  5 (15; 7-31) 
a lack of equipment  6 (32; 15-54)  6 (18; 9-34) 
Sympathetic bimodal fitting (Section 2c)   
Numbers who indicated…   
a lack of time to fit both devices in the same session 11 (58; 36-77) 17 (52; 35-67) 
a lack of guidelines on optimising bimodal fittings 12 (63; 41-81) 18 (55; 38-70) 
 
  No. 
centres 
(%; 95%CI) 
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respondents 
(%; 95%CI) 
HA management (Section 3a)   
During candidacy assessment. Numbers who indicated…   
it is the role of the CI audiologist to evaluate HAs 13 (68; 46-85) 15 (42; 27-58) 
it is beneficial to optimise HAs 18 (95; 75-99) 33 (92; 78-97) 
During subsequent reviews. Numbers who indicated…   
it is the role of the CI audiologist to evaluate contralateral 
HAs 
15 (79; 51-88) 20 (61; 50-80) 
it is beneficial to optimise the contralateral HA 18 (95; 75-99) 30 (91; 76-97) 
Bimodal benefit (section 3b)   
Numbers who indicated…   
Consideration of bimodal aiding when choosing the CI ear  16 (84; 62-94) 21 (64; 47-48) 
bimodal aiding is more beneficial than CI-alone 16 (84; 62-94) 28 (85; 69-93) 
it is clinically useful to measure bimodal benefit 18 (95; 75-99) 30 (91; 76-97) 
Sympathetic bimodal fitting (Section 3c)   
Numbers who indicated…   
sympathetic device fitting could improve outcomes 16 (84; 62-94) 27 (82; 66-91) 
a recently re-fit HA is more beneficial than an older fitting  15 (79; 57-91) 26 (79; 62-89) 
wearing a previously-fit HA can still provide bimodal 
benefits 
16 (84; 62-94) 26 (79; 62-89) 
Further guidance (section 3d)   
Numbers who indicated a need for guidance on…   
maximising bimodal benefit 18 (100; 82-100) 31 (97; 85-99) 
optimising bimodal fitting 16 (89; 67-97) 29 (91; 76-97) 
identifying  bimodal candidates 14 (78; 55-91) 23 (72; 55-84) 
measuring bimodal benefit 16 (89; 67-97) 28 (88; 72-95) 
when to reintroduce the HA post-CI 15 (83; 61-94) 26 (81; 65-91) 
how to advise patients on bimodal listening 16 (89; 67-97) 27 (84; 68-93) 
 
 
